Escalon Medical CORP Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
OQB
LPL Financial LLC has reported beneficial ownership of 7.9% of Escalon Medical Corp.'s common stock as of March 31, 2026.
OQB
Charles C. Newton has reported a 0% beneficial ownership in Escalon Medical Corp., indicating a full divestment of his previous stake.
OQB
Charles C. Newton has disclosed a 6.3% beneficial ownership stake in Escalon Medical Corp., holding 467,895 shares of common stock.
OQB
Newton Charles Carter has filed an amended Schedule 13G, disclosing a 6.2% beneficial ownership stake in Escalon Medical Corp., indicating a passive investment.
OQB
Charles C Newton has filed a Schedule 13G, disclosing a 6.2% beneficial ownership stake in Escalon Medical Corp.'s common stock as of May 19, 2025.